PacBio Onso™ short read sequencing instrument joins 10X Genomics compatible partner program

PacBio (PACB), a leading developer of high-quality, highly accurate genomic sequencing solutions, today announced the inclusion of the Onso short-read sequencing platform in the 10x Genomics Compatible Partner Program. The 10x Genomics Compatible Partner Program recognizes instruments and workflows compatible with 10x Genomics' products and applications, thereby broadening the range of sequencing solutions available to researchers worldwide.

The Onso platform, designed to provide exceptional accuracy and performance in short-read sequencing, is well-aligned with 10x Genomics' suite of tools for single-cell and spatial biology applications. The Onso platform joins PacBio's MAS-seq long read RNA sequencing solution in the 10x Genomics Compatible Partner Program, as part of PacBio's effort to empower scientists with integrated workflows that enhance insights into genomics and transcriptomics, addressing key challenges in scientific research and advancing discovery in health and disease.

"We are excited to expand our partnership with 10x Genomics, an established leader in single-cell and spatial biology solutions," said David Miller, VP of Global Marketing at PacBio. "The integration of our Onso short read sequencing instrument into their partner program signifies a major step forward for researchers looking for high-performance sequencing with superior accuracy. This collaboration will help expand the possibilities for discovery in complex biological systems and enhance our ability to support cutting-edge research in genomics."

Benefits of the collaboration:

  • Streamlined Workflows: Researchers can now access seamless end-to-end solutions by combining PacBio's Onso platform with 10x Genomics' technologies, allowing for improved data quality and efficiency.
  • Enhanced Applications: The Onso platform is compatible with 10x Genomics' Single Cell 3' v3.1 assay.
  • Industry-Leading Accuracy: PacBio's Onso platform delivers unmatched sequencing accuracy, further enhancing the precision of 10x Genomics' cutting-edge research tools.

We are thrilled to welcome the PacBio Onso platform into the 10x Genomics Compatible Partner Program. PacBio's innovative approach to short read sequencing, paired with our leading single-cell technologies, provides an integrated solution that will enable researchers to push the boundaries of genomic science."

Rena Bradham, VP and Global Head of Marketing, 10x Genomics

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    PacBio. (2024, October 23). PacBio Onso™ short read sequencing instrument joins 10X Genomics compatible partner program. News-Medical. Retrieved on November 23, 2024 from https://www.news-medical.net/news/20241023/Pacbio-Onsoe284a2-short-read-sequencing-instrument-joins-10X-Genomics-compatible-partner-program-Pacbio.aspx.

  • MLA

    PacBio. "PacBio Onso™ short read sequencing instrument joins 10X Genomics compatible partner program". News-Medical. 23 November 2024. <https://www.news-medical.net/news/20241023/Pacbio-Onsoe284a2-short-read-sequencing-instrument-joins-10X-Genomics-compatible-partner-program-Pacbio.aspx>.

  • Chicago

    PacBio. "PacBio Onso™ short read sequencing instrument joins 10X Genomics compatible partner program". News-Medical. https://www.news-medical.net/news/20241023/Pacbio-Onsoe284a2-short-read-sequencing-instrument-joins-10X-Genomics-compatible-partner-program-Pacbio.aspx. (accessed November 23, 2024).

  • Harvard

    PacBio. 2024. PacBio Onso™ short read sequencing instrument joins 10X Genomics compatible partner program. News-Medical, viewed 23 November 2024, https://www.news-medical.net/news/20241023/Pacbio-Onsoe284a2-short-read-sequencing-instrument-joins-10X-Genomics-compatible-partner-program-Pacbio.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Comments are closed

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.